Mantle Cell Lymphoma (MCL) Enrolling by Invitation Phase 3 Trials for Ibrutinib (DB09053)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Enrolling by Invitation3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01804686A Long-term Extension Study of PCI-32765 (Ibrutinib)Treatment